Experimental in vitro and in vivo models for the study of human hepatitis B virus infection.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Journal of Hepatology

• Publication date

  2016-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.jhep.2016.02.012PMID 27084033
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evidence that hepatitis B virus replication in mouse cells is limited by the lack of a host cell dependency factor.

  2016cited by this paper
• A targeted functional RNA interference screen uncovers glypican 5 as an entry factor for hepatitis B and D viruses

  2016cited by this paper
• Identification of FDA‐approved drugs that target hepatitis B virus transcription

  2016cited by this paper
• Targeting hepatitis B virus cccDNA using CRISPR/Cas9.

  2015cited by this paper
• Does Tyrosyl DNA Phosphodiesterase-2 Play a Role in Hepatitis B Virus Genome Repair?

  2015cited by this paper
• The chimpanzee model for hepatitis B virus infection.

  2015cited by this paper
• Harnessing the clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated Cas9 system to disrupt the hepatitis B virus

  2015cited by this paper
• C-terminal-truncated hepatitis B virus X protein enhances the development of diethylnitrosamine-induced hepatocellular carcinogenesis.

  2015cited by this paper
• Early inhibition of hepatocyte innate responses by hepatitis B virus.

  2015cited by this paper
• The Woodchuck, a Nonprimate Model for Immunopathogenesis and Therapeutic Immunomodulation in Chronic Hepatitis B Virus Infection.

  2015cited by this paper
• Combinatorial RNA Interference Therapy Prevents Selection of Pre-existing HBV Variants in Human Liver Chimeric Mice

  2015cited by this paper
• Inhibition of hepatitis B virus by the CRISPR/Cas9 system via targeting the conserved regions of the viral genome.

  2015cited by this paper
• HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B

  2015cited by this paper
• Expression and functionality of Toll- and RIG-like receptors in HepaRG cells.

  2015cited by this paper
• Adeno-Associated Virus Vector Mediated Delivery of the HBV Genome Induces Chronic Hepatitis B Virus Infection and Liver Fibrosis in Mice

  2015cited by this paper
• Targeting hepatitis B virus cccDNA by CRISPR/Cas9 nuclease efficiently inhibits viral replication.

  2015cited by this paper
• The Dual Role of an ESCRT-0 Component HGS in HBV Transcription and Naked Capsid Secretion

  2015cited by this paper
• A Novel Mouse Model for Stable Engraftment of a Human Immune System and Human Hepatocytes

  2015cited by this paper
• HBx relieves chromatin-mediated transcriptional repression of hepatitis B viral cccDNA involving SETDB1 histone methyltransferase.

  2015influential reference
• Prolonged suppression of HBV in mice by a novel antibody that targets a unique epitope on hepatitis B surface antigen

  2015cited by this paper
• High persistence rate of hepatitis B virus in a hydrodynamic injection-based transfection model in C3H/HeN mice.

  2015cited by this paper
• Inhibition of replication of hepatitis B virus in transgenic mice following administration of hepatotropic lipoplexes containing guanidinopropyl-modified siRNAs.

  2015cited by this paper
• Hepatitis D Virus Infection of Mice Expressing Human Sodium Taurocholate Co-transporting Polypeptide

  2015cited by this paper
• Hepatitis B surface antigen (HBsAg) and core antigen (HBcAg) combine CpG oligodeoxynucletides as a novel therapeutic vaccine for chronic hepatitis B infection.

  2015cited by this paper
• Animal models and the molecular biology of hepadnavirus infection.

  2015cited by this paper
• Characterization of novel entecavir resistance mutations.

  2015cited by this paper
• The RNA sensor RIG-I dually functions as an innate sensor and direct antiviral factor for hepatitis B virus.

  2015cited by this paper
• The Interferon-Inducible Protein Tetherin Inhibits Hepatitis B Virus Virion Secretion

  2015cited by this paper
• CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus

  2015cited by this paper
• Chronic hepatitis B virus infection and occurrence of hepatocellular carcinoma in tree shrews (Tupaia belangeri chinensis)

  2015cited by this paper
• Mouse models for therapeutic vaccination against hepatitis B virus

  2015cited by this paper
• Complete replication of hepatitis B virus and hepatitis C virus in a newly developed hepatoma cell line

  2014cited by this paper
• Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes.

  2014cited by this paper
• Lentiviral backbone-based hepatitis B virus replicon-mediated transfer favours the establishment of persistent hepatitis B virus infection in mice after hydrodynamic injection.

  2014cited by this paper
• Specific and Nonhepatotoxic Degradation of Nuclear Hepatitis B Virus cccDNA

  2014cited by this paper
• Immune cell responses are not required to induce substantial hepatitis B virus antigen decline during pegylated interferon-alpha administration.

  2014cited by this paper
• O102 PROLIFERATION OF HBV-INFECTED HUMAN HEPATOCYTES IN HUMANIZED MICE PROMOTES THE OCCURRENCE OF VIRAL INTEGRATIONS WITHIN THE HOST GENOME

  2014cited by this paper
• Involvement of the host DNA-repair enzyme TDP2 in formation of the covalently closed circular DNA persistence reservoir of hepatitis B viruses

  2014cited by this paper
• DDX3 DEAD-Box RNA Helicase Is a Host Factor That Restricts Hepatitis B Virus Replication at the Transcriptional Level

  2014cited by this paper
• Extensive double humanization of both liver and hematopoiesis in FRGN mice

  2014cited by this paper
• Hepatitis virus infection affects DNA methylation in mice with humanized livers.

  2014cited by this paper
• The CRISPR/Cas9 System Facilitates Clearance of the Intrahepatic HBV Templates In Vivo

  2014cited by this paper
• Human hepatocytes and hematolymphoid dual reconstitution in treosulfan-conditioned uPA-NOG mice.

  2014cited by this paper
• Binding of hepatitis B virus to its cellular receptor alters the expression profile of genes of bile acid metabolism

  2014cited by this paper
• Modeling host interactions with hepatitis B virus using primary and induced pluripotent stem cell-derived hepatocellular systems

  2014cited by this paper
• HBV life cycle is restricted in mouse hepatocytes expressing human NTCP

  2014cited by this paper
• Evaluation and identification of hepatitis B virus entry inhibitors using HepG2 cells overexpressing a membrane transporter NTCP.

  2014cited by this paper
• Simultaneous detection of hepatitis C virus and interferon stimulated gene expression in infected human liver

  2014influential reference
• Hepatitis B: future curative strategies

  2014cited by this paper
• Alisporivir Inhibition of Hepatocyte Cyclophilins Reduces HBV Replication and Hepatitis B Surface Antigen Production

  2014cited by this paper
• Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor.

  2014cited by this paper
• Hepatitis B Virus Infection and Immunopathogenesis in a Humanized Mouse Model: Induction of Human-Specific Liver Fibrosis and M2-Like Macrophages

  2014influential reference
• Mouse models of hepatitis B and delta virus infection.

  2014cited by this paper
• Recombinant Covalently Closed Circular Hepatitis B Virus DNA Induces Prolonged Viral Persistence in Immunocompetent Mice

  2014cited by this paper
• Chimeric Mouse Model for the Infection of Hepatitis B and C Viruses

  2013influential reference
• The amino acid substitutions rtP177G and rtF249A in the reverse transcriptase domain of hepatitis B virus polymerase reduce the susceptibility to tenofovir.

  2013cited by this paper
• The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus.

  2013influential reference
• Molecular Determinants of Hepatitis B and D Virus Entry Restriction in Mouse Sodium Taurocholate Cotransporting Polypeptide

  2013cited by this paper
• Discovery of naturally occurring transmissible chronic hepatitis B virus infection among Macaca fascicularis from mauritius island

  2013cited by this paper
• Targeted Induction of Interferon-λ in Humanized Chimeric Mouse Liver Abrogates Hepatotropic Virus Infection

  2013influential reference
• Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME

  2013cited by this paper
• A mouse model for HBV immunotolerance and immunotherapy

  2013cited by this paper
• Intrahepatic myeloid-cell aggregates enable local proliferation of CD8+ T cells and successful immunotherapy against chronic viral liver infection

  2013influential reference
• A novel therapeutic hepatitis B vaccine induces cellular and humoral immune responses and breaks tolerance in hepatitis B virus (HBV) transgenic mice.

  2013cited by this paper
• GS-9620, an oral agonist of Toll-like receptor-7, induces prolonged suppression of hepatitis B virus in chronically infected chimpanzees.

  2013cited by this paper
• Adeno-Associated Virus-Mediated Gene Transfer Leads to Persistent Hepatitis B Virus Replication in Mice Expressing HLA-A2 and HLA-DR1 Molecules

  2013cited by this paper
• A novel TK-NOG based humanized mouse model for the study of HBV and HCV infections.

  2013influential reference
• IFN-α inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome.

  2012influential reference
• Transfer of HBV genomes using low doses of adenovirus vectors leads to persistent infection in immune competent mice.

  2012cited by this paper
• Chronic hepatitis B infection.

  2012cited by this paper
• Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluation

  2012influential reference
• Severe necroinflammatory reaction caused by natural killer cell‐mediated Fas/Fas ligand interaction and dendritic cells in human hepatocyte chimeric mouse

  2012cited by this paper
• Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus

  2012cited by this paper
• Chimeric mouse model of hepatitis B virus infection.

  2012cited by this paper
• Hepatitis B virus–induced lipid alterations contribute to natural killer T cell–dependent protective immunity

  2012cited by this paper
• A humanized mouse model to study hepatitis C virus infection, immune response, and liver disease.

  2011cited by this paper
• Sequential control of hepatitis B virus in a mouse model of acute, self‐resolving hepatitis B

  2011cited by this paper
• 5' Triphosphorylated small interfering RNAs control replication of hepatitis B virus and induce an interferon response in human liver cells and mice.

  2011cited by this paper
• Effects of hepatitis B virus infection on the interferon response in immunodeficient human hepatocyte chimeric mice.

  2011cited by this paper
• Hepatitis B virus limits response of human hepatocytes to interferon-α in chimeric mice.

  2011cited by this paper
• The reconstituted 'humanized liver' in TK-NOG mice is mature and functional.

  2011cited by this paper
• HBx protein is indispensable for development of viraemia in human hepatocyte chimeric mice.

  2010cited by this paper
• Highly efficient generation of human hepatocyte–like cells from induced pluripotent stem cells

  2010cited by this paper
• Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatment.

  2010influential reference
• Hepatitis B virus replication in primary macaque hepatocytes: Crossing the species barrier toward a new small primate model

  2010cited by this paper
• Control of hepatitis B virus replication by innate response of HepaRG cells

  2010cited by this paper
• In vivo proliferation of hepadnavirus‐infected hepatocytes induces loss of covalently closed circular DNA in mice

  2010cited by this paper
• A mouse model of inducible liver injury caused by tet-on regulated urokinase for studies of hepatocyte transplantation.

  2009cited by this paper
• Hepatitis B virus resistance to nucleos(t)ide analogues.

  2009cited by this paper
• The Size of the Viral Inoculum Contributes to the Outcome of Hepatitis B Virus Infection

  2009cited by this paper
• Persistence of the hepatitis B virus covalently closed circular DNA in HepaRG human hepatocyte-like cells.

  2009influential reference
• Temporal analysis of early immune responses in patients with acute hepatitis B virus infection.

  2009cited by this paper
• Control of cccDNA function in hepatitis B virus infection.

  2009cited by this paper
• Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein

  2008cited by this paper
• The human liver-uPA-SCID mouse: a model for the evaluation of antiviral compounds against HBV and HCV.

  2008cited by this paper
• Initiation of hepatitis B virus genome replication and production of infectious virus following delivery in HepG2 cells by novel recombinant baculovirus vector.

  2008cited by this paper
• The antiviral drug selected hepatitis B virus rtA181T/sW172* mutant has a dominant negative secretion defect and alters the typical profile of viral rebound

  2008cited by this paper
• Detection of Clonally Expanded Hepatocytes in Chimpanzees with Chronic Hepatitis B Virus Infection

  2008cited by this paper
• Hepatitis B virus infection initiates with a large surface protein-dependent binding to heparan sulfate proteoglycans.

  2007cited by this paper
• Repopulation of adult and neonatal mice with human hepatocytes: A chimeric animal model

  2007cited by this paper

• Human hepatic cell line 5: In-vitro model for hepatic immunobiology

  2026cites this paper
• Myricetin supresses HBV replication both in vitro and in vivo via inhibition of HBV promoter SP2.

  2025cites this paper
• The Evolution of Cell Culture Systems to Study Hepatitis B Virus Pathogenesis and Antiviral Susceptibility

  2025cites this paper
• AAV-HBV mouse model replicates the intrahepatic immune landscape of chronic HBV patients at single-cell level

  2025cites this paper
• in-text ref citation test High-pressure Hydrodynamic Injection as a Method of Establishing Hepatitis B Virus Infection in Mice

  2024cites this paper
• Intrahepatic Exhausted Antiviral Immunity in an Immunocompetent Mouse Model of Chronic Hepatitis B

  2024cites this paper
• Mice Engrafted with Human Liver Cells

  2024cites this paper
• Identification of amino acids restricting HBV receptor function in porcine NTCP

  2024cites this paper
• Hepatic macrophage niche: a bridge between HBV-mediated metabolic changes with intrahepatic inflammation

  2024cites this paper
• Exploring in vitro modeling in hepatocarcinogenesis research: morphological and molecular features and similarities to the corresponding human disease.

  2024cites this paper
• Progress of Infection and Replication Systems of Hepatitis B Virus.

  2024cites this paper
• Hepatocyte Intrinsic Innate Antiviral Immunity against Hepatitis Delta Virus Infection: The Voices of Bona Fide Human Hepatocytes

  2024cites this paper
• Major open questions in the hepatitis B and D field - Proceedings of the inaugural International emerging hepatitis B and hepatitis D researchers workshop.

  2024cites this paper
• ISG12a promotes immunotherapy of HBV-associated hepatocellular carcinoma through blocking TRIM21/AKT/β-catenin/PD-L1 axis

  2024cites this paper
• Exploring in vivo and in vitro infection models in brucellosis research: A mini-review

  2024cites this paper
• High-pressure Hydrodynamic Injection as a Method of Establishing Hepatitis B Virus Infection in Mice.

  2024cites this paper
• MDSC-targeted liposomal all-trans retinoic acid suppresses mMdscs and improves immunotherapy in HBV infection

  2024cites this paper
• Three-dimensional liver organoids as a novel platform for studying hepatitis B virus infection

  2024cites this paper
• Mechanisms of hepatocellular carcinoma and cirrhosis development in concurrent steatotic liver disease and chronic hepatitis B

  2024cites this paper
• Long-term 3D cell culture models for hepatitis B virus studies.

  2024cites this paper
• HBV with precore and basal core promoter mutations exhibits a high replication phenotype and causes ER stress-mediated cell death in humanized liver chimeric mice

  2023cites this paper
• AAV-HBV mouse model replicates immune exhaustion patterns of chronic HBV patients at single-cell level

  2023cites this paper
• Cell Culture Systems for Studying Hepatitis B and Hepatitis D Virus Infections

  2023cites this paper
• Liver organoids as a primary human model to study HBV-mediated Hepatocellular carcinoma. A review.

  2023cites this paper
• Forthcoming Developments in Models to Study the Hepatitis B Virus Replication Cycle, Pathogenesis, and Pharmacological Advancements

  2023cites this paper
• Potential antiviral activities of chrysin against hepatitis B virus

  2023cites this paper
• Liver-Humanized NSG-PiZ Mice Support the Study of Chronic Hepatitis B Virus Infection and Antiviral Therapies

  2022cites this paper
• Naturally occurring HMGB1 inhibitor delineating the anti-hepatitis B virus mechanism of glycyrrhizin via in vitro and in silico studies

  2022cites this paper
• A novel cDNA‐uPA/SCID/Rag2−/−/Jak3−/− mouse model for hepatitis virus infection and reconstruction of human immune system

  2022cites this paper
• Physiomimetic In Vitro Human Models for Viral Infection in the Liver

  2022influential citation
• Studying Hepatitis Virus-Host Interactions in Patient Liver Biopsies

  2022cites this paper
• Innate Immunity, Inflammation, and Intervention in HBV Infection

  2022cites this paper
• HBV immune tolerance of HBs-transgenic mice observed through parabiosis with WT mice

  2022cites this paper
• Establishment and Characterization of an HBV Viral Spread and Infectious System following Long-Term Passage of an HBV Clinical Isolate in the Primary Human Hepatocyte and Fibroblast Coculture System

  2022cites this paper
• Molecular and biological characterization of hepatitis B virus subgenotype F1b clusters: Unraveling its role in hepatocarcinogenesis

  2022cites this paper
• Cell Culture Models for the Study of Hepatitis D Virus Entry and Infection

  2021cites this paper
• Hepatitis B virus infection modeling using multi-cellular organoids derived from human induced pluripotent stem cells

  2021cites this paper
• Application of human liver organoids as a patient-derived primary model for HBV infection and related hepatocellular carcinoma

  2021cites this paper
• Intramolecular recombination enables the formation of hepatitis B virus (HBV) cccDNA in mice after HBV genome transfer using recombinant AAV vectors.

  2021cites this paper
• Circadian control of hepatitis B virus replication

  2021cites this paper
• Establishment of Humanized Mice for the Study of HBV

  2021cites this paper
• In Vitro Infection with Hepatitis B Virus Using Differentiated Human Serum Culture of Huh7.5-NTCP Cells without Requiring Dimethyl Sulfoxide

  2021cites this paper
• In silico Analysis of a Novel Peptide Vaccine against Hepatitis B Virus (HBV)

  2021cites this paper
• In Vivo Mouse Models for Hepatitis B Virus Infection and Their Application

  2021influential citation
• Screening and identification of dominant monoclonal HepG2 cell strain with 1.3-fold HBV genome

  2021cites this paper
• Are Humanized Mouse Models Useful for Basic Research of Hepatocarcinogenesis through Chronic Hepatitis B Virus Infection?

  2021cites this paper
• Establishment of a Mouse Model of Chronic Hepatitis B Virus Infection and Purification of Hepatic Parenchymal and Non-Parenchymal Cells

  2021cites this paper
• Dietary Approaches for Management of Non-Alcoholic Fatty Liver Disease: A Clinician’s Guide

  2021cites this paper
• Unmet Needs in Basic Research of Hepatitis B Virus Infection: In Vitro and In Vivo Models

  2021cites this paper
• Curcumin inhibited hepatitis B viral entry through NTCP binding

  2021cites this paper
• A novel recombinant cccDNA-based mouse model with long term maintenance of rcccDNA and antigenemia.

  2020cites this paper
• Chronic hepatitis B and non‐alcoholic fatty liver disease: Conspirators or competitors?

  2020cites this paper
• Art of Making Artificial Liver: Depicting Human Liver Biology and Diseases in Mice

  2020cites this paper
• In-vitro and in-vivo models for hepatitis B cure research.

  2020cites this paper
• Liver Disease Modelling

  2020cites this paper
• In Vitro Systems for Studying Different Genotypes/Sub-Genotypes of Hepatitis B Virus: Strengths and Limitations

  2020cites this paper
• HBV replication inhibitors.

  2020cites this paper
• In vitro transcribed MRNA for expression of designer nucleases: advantages as a novel therapeutic for the management of chronic HBV infection.

  2020cites this paper
• In vitro inhibition effects of hepatitis B virus by dandelion and taraxasterol

  2020cites this paper
• Animal models for the study of human hepatitis B and D virus infection: new insights and progress.

  2020cites this paper
• Synchronised infection identifies early rate-limiting steps in the hepatitis B virus life cycle

  2020cites this paper
• Impact of Hepatitis B Virus Genetic Variation, Integration, and Lymphotropism in Antiviral Treatment and Oncogenesis

  2020cites this paper
• Insights into Hepatitis B Virus DNA Integration-55 Years after Virus Discovery

  2020cites this paper
• INVITRO STUDY FOR THE OPTIMAL PRODUCTION OF HEPATITIS B VIRUS SUBVIRAL PARTICLES FOR MEDICAL PURPOSES

  2020cites this paper
• CRISPR-Cas9 gene editing of hepatitis B virus in chronically infected humanized mice

  2020cites this paper
• Modeling Infectious Diseases in Mice with a “Humanized” Immune System

  2019cites this paper
• Human liver organoids; a patient-derived primary model for HBV Infection and Related Hepatocellular Carcinoma

  2019cites this paper
• Liver chimeric mice with tupaia hepatocyte transplantation as an animal model for hepatitis B virus infection and antiviral therapy

  2019cites this paper
• Mapping the Heterogeneity of Histone Modifications on Hepatitis B Virus DNA Using Liver Needle Biopsies Obtained from Chronically Infected Patients

  2019cites this paper
• HBV infection-induced liver cirrhosis development in dual-humanised mice with human bone mesenchymal stem cell transplantation

  2019cites this paper
• Identification and characterization of SEC24D as a susceptibility gene for hepatitis B virus infection

  2019cites this paper
• An Immortalized Hepatocyte-Like Cell Line (imHC) Accommodated Complete Viral Lifecycle, Viral Persistence Form, cccDNA and Eventual Spreading of a Clinically-Isolated HBV

  2019cites this paper
• Cell and Animal Models for Studying Hepatitis B Virus Infection and Drug Development.

  2019cites this paper
• Inhibition of interferon signaling during Hepatitis B Virus infection and virus-associated hepatocellular carcinoma

  2019influential citation
• Interferon signaling during Hepatitis B Virus (HBV) infection and HBV-associated hepatocellular carcinoma.

  2019cites this paper
• T Lymphocytes Attenuate Dermal Scarring by Regulating Inflammation, Neovascularization, and Extracellular Matrix Remodeling

  2019cites this paper
• HBV-related hepatocarcinogenesis: the role of signalling pathways and innovative ex vivo research models

  2019cites this paper
• Humanized mouse models for human viral hepatitis and related liver diseases

  2019cites this paper
• Impact of length of replication competent genome of hepatitis B virus over the differential antigenic secretion

  2019cites this paper
• Bona fide receptor for hepatitis B and D viral infections: Mechanism, research models and molecular drug targets

  2018cites this paper
• NVR 3-778 Plus Pegylated Interferon-α Treatment for Chronic Hepatitis B Viral Infections: Could 1 + 1 = 3?

  2018cites this paper
• A virus‐like particle of the hepatitis B virus preS antigen elicits robust neutralizing antibodies and T cell responses in mice

  2018cites this paper
• Hepatitis B virus sensitivity to interferon‐α in hepatocytes is more associated with cellular interferon response than with viral genotype

  2018cites this paper
• Efficacy of hepatitis B virus ribonuclease H inhibitors, a new class of replication antagonists, in FRG human liver chimeric mice

  2018cites this paper
• Virus entry and its inhibition to prevent and treat hepatitis B and hepatitis D virus infections.

  2018cites this paper
• A Chimeric Humanized Mouse Model by Engrafting the Human Induced Pluripotent Stem Cell-Derived Hepatocyte-Like Cell for the Chronic Hepatitis B Virus Infection

  2018cites this paper
• Unmet Needs in Basic Research: In Vitro and In Vivo Models

  2018cites this paper
• Polymer–drug conjugate therapeutics: advances, insights and prospects

  2018cites this paper
• Hepatitis B Virus Blood Screening: Need for Reappraisal of Blood Safety Measures?

  2018cites this paper
• Optimized HepaRG is a suitable cell source to generate the human liver chimeric mouse model for the chronic hepatitis B virus infection

  2018cites this paper
• The functional role of sodium taurocholate cotransporting polypeptide NTCP in the life cycle of hepatitis B, C and D viruses

  2018cites this paper
• The natural compound silvestrol inhibits hepatitis E virus (HEV) replication in vitro and in vivo

  2018cites this paper
• Mouse models of hepatocellular carcinoma: an overview and highlights for immunotherapy research

  2018cites this paper
• Recombinant vaccinia vector-based vaccine (Tiantan) boosting a novel HBV subunit vaccine induced more robust and lasting immunity in rhesus macaques.

  2017cites this paper
• A novel orally available small molecule that inhibits hepatitis B virus expression.

  2017cites this paper
• Toward novel immunocompetent animal models for hepatitis B virus infection

  2017influential citation
• The potential and challenges of CRISPR-Cas in eradication of hepatitis B virus covalently closed circular DNA.

  2017cites this paper
• Potential damaging mutation in LRP5 from genome sequencing of the first reported chimpanzee with the Chiari malformation

  2017cites this paper
• Inhibition of hepatitis B virus in HepG 2 . 2 . 15 by indirubin through suppression of a polypyrimidine tract-binding protein

  2017cites this paper
• Efficacy of NVR 3-778, Alone and In Combination With Pegylated Interferon, vs Entecavir In uPA/SCID Mice With Humanized Livers and HBV Infection.

  2017cites this paper